Please assess the completion status of the following clinical trial:

Trial Title: PK Intravenous Lidocaine Infusion

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* male or female children 3-15 years of age~* ASA physical status 1-3~* scheduled for colorectal surgery with abdominal incision~Exclusion Criteria:~* ASA physical status \> 3~* postoperative intubation planned ahead of surgery~* history of chronic use of opioid (use longer than 3 months)~* history of hepatic, renal, or cardiac failure~* history of significant liver disease including liver failure, acute or chronic hepatitis, hepatomegaly, portal hypertension and elevated liver enzymes~* history of organ transplant~* BMI \> 30~* history of cardiac arrhythmia~* history of long QT syndrome~* history of allergic reaction to lidocaine or similar agents~* history of seizure disorder~* patient without PICC or other central access with contraindication to inhalation induction~* family history or known patient susceptibility to malignant hyperthermia

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 15 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: EXPERIMENTAL): IV lidocaine bolus of 1.5mg/kg over 10 minutes followed by a 1mg/kg/hr IV lidocaine infusion.

Based on this trial design, predict the completion outcome and termination type (if applicable).